India’s equity markets are set for a firm open on Wednesday, with the GIFT Nifty trading over 80 points higher at around 8.30am, signaling a positive start to the day. This comes after a volatile session on Tuesday, where the Nifty touched fresh 2025 highs but closed sharply off those levels, shedding nearly 300 points intraday as profit-taking emerged.
The mid-week session is likely to be influenced by a combination of expiry-led volatility - given the Sensex derivatives monthly expiry - and caution ahead of the much-anticipated HDB Financial Services IPO. Despite a supportive global backdrop and a sharp fall in crude oil prices, the Nifty struggled to sustain at elevated levels.
On Wall Street, benchmark indices inched closer to record highs overnight, offering some support to domestic sentiment. However, traders will also keep a close watch on the Reserve Bank of India’s ₹1 lakh crore Variable Rate Reverse Repo (VRRR) auction scheduled for Friday, aimed at withdrawing excess liquidity from the banking system.
In sectoral action, defence stocks could remain under pressure after witnessing profit booking on Tuesday.
Here are the key stocks to watch on June 25, 2025:
Timex Group India: Promoter entity Timex Group Luxury Watches BV (Netherlands) will offload up to 15% stake via Offer for Sale (OFS) on June 25–26. The base offer includes a 7.5% stake (75.71 lakh shares). The OFS opens for non-retail investors today, and for retail investors tomorrow. The floor price is set at ₹175 per share.
Hindalco Industries: The company’s step-down US subsidiary, Aditya Holdings LLC, has entered into a definitive agreement to acquire AluChem Companies Inc, a US-based specialty alumina manufacturer, for $125 million.
Infosys: The IT major has announced a strategic partnership with Zoetis, a global leader in animal health, to enhance the company’s digital infrastructure through AI and automation-driven solutions.
Tata Motors: Jaguar Land Rover (JLR), the company’s UK luxury vehicle arm, may face a £1.6 billion tariff hit under new US trade policy proposals expected if Donald Trump returns to power. The move could significantly raise costs for foreign auto manufacturers.
Aurobindo Pharma: Its step-down subsidiary, CuraTeQ Biologics sro, has secured marketing authorization from the UK’s MHRA for Dyrupeg, a biosimilar version of pegylated filgrastim.
JB Chemicals & Pharmaceuticals: The company has received USFDA approval for its generic version of Amitriptyline Hydrochloride tablets, used to treat depression, in multiple dosage strengths.
PTC Industries: Subsidiary Aerolloy Technologies has signed an MoU with Safran Aircraft Engines to manufacture key components and materials for military aircraft engines in India, marking a significant development in the country’s defence manufacturing ambitions.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here